Myths & Misconceptions About Methadone

Myth #1: Methadone is Addicting

Methadone is not considered a primary drug of choice for "getting high."

Methadone is administered orally, and compared to most opiates, is slow to take effect.

Methadone does not produce a "rush" like other narcotics.

Myth #2: People Get High On Methadone

Methadone is an opiate blocker, which means that it blocks the craving for opiates once the methadone is ingested.

The "blocking" effect of methadone helps the individual "normalize" their life again.

The "blocking" effect lasts for 24 hours, so the individual will have an opportunity to "unravel" the addict way of thinking.

Once an individual is taking the appropriate dosage, there is no impairment of motor skills or thinking ability (as long as no other psychoactive drugs are taken with it).

Myth #3: Once on Methadone, You Cannot Stop Using It

The first goal of Medically Assisted Treatment is to eliminate the use of opiates.

Methadone is a "tool" used to eliminate the cravings and withdrawal symptoms associated with opiates.

Full participation of individual and group counseling is necessary to change the addictive behaviors of one suffering with addiction. This allows the individual the best opportunity for a successful detox from Methadone.

Myth #4: Methadone Does No Good

Methadone decreases the exposure of diseases as HIV and Hepatitis.

Methadone decreases the possibility of overdoses.

Methadone decreases the amount of drug related crime.

Myth #5: Methadone Hurts Your Health

The health status of methadone patients has been studied more frequently than other medications.

There is no scientific evidence that methadone rots teeth, gets into bones, or causes any other health issues. Extensive drug abuse can lead to neglect of personal hygiene, which can cause health issues.

Taking methadone is safe for expectant mothers.

The above information was summarized from "Myths About Methadone", by Emmett Velten, National Alliance of Methadone Advocates, Education Series Number Three, March, 1992.